Direct answer:The registration and operation of the medical device enterprise, which records the equipment and activities in question, is judged separately by the real role. The offshore application facility should be registered prior to export to the United States; Products requiring a pre-market permit must meet the corresponding requirements. Extensions and listing reviews are carried out annually and registration or listings do not amount to FDA approval.

The determination of who is registered, who is listed and who is paying the fees begins with the identification of what the parties actually do. Manufacturers, contract manufacturers, specifications developers, initial importers and U.S. agents cannot substitute for one another by the name of the contract alone.

I. Which actors ' obligations need to be checked separately?

  • Manufacturers, applicable contract manufacturers and contract cleaners: Registration, listing and payment should be checked against the actual activities of the facility.
  • Speculation developers, repackaging or labelling enterprises: Obligations cannot be automatically excluded because they are not produced in person, and real activities should be seen.
  • United States initial importer: the FDA activity form requires registration and identification of the manufacturer and cannot directly apply the manufacturer’s listing arrangement.
  • Subjects engaged only in specific distribution or brokering activities: may be different from manufacturing or initial import roles, and specific conditions need to be checked.

Whether brand parties are specifications developers and traders are offshore exporters should be judged on the basis of activities and FDA definitions, rather than on the name of the business licence alone.

II. What is the difference between registration, listing, pre-market licensing and UDI?

  • Business register: Recording facilities, operations and related contact information.
  • Produc listing: records are created by data on the corresponding equipment, product code, activity and pre-market status.
  • Pre-market path: a check of the applicable 510(k), De Novo, PMA or exemption basis cannot be completed by registration.
  • UDI/GUDID: Processing labelling and packaging identification and instrument master data, which cannot be replaced by listing records.

I'll see the path.510(k), De Novo and PMA GuideI'll see you about marking.UDI and GUID Guide。

III. What information is to be prepared before the first processing?

  • Statutory subjects, names of physical facilities in English and addresses, real business activities and relationships.
  • Owner/Operator, Office Correspondent, etc., applies the authority to head, contact and account number.
  • Information such as U.S. agent arrangements for offshore facilities and applicable importers.
  • Product name, model, classification product code, manufacturing and other activities.
  • Apply pre-market numbers or the basis of the exemption judgement, as well as current label information.
  • Registered, listed, FEI or other relevant records and authorizations exist; Applying contributory information separately.

When the relevant number is not available for the first time, records should be established according to the correct process and other business or other location numbers should be avoided. U.S. agent's liaison duties and the identity of the importer should also be identified separately.

IV. What is the order of first registration and listing?

If the product code or listing basis has not been confirmed before processing, reference may be made.Project Code Query GuideCheck when you need to check further510(k) Exemption assessment services。 Enterprises with a clear path throughSummary service masterSelect the first registration, listing or maintenance entrance.

The classification of products and pre-marketing conditions are defined, facilities and operating roles are checked, account numbers and historical records are available, and arrangements are made for the submission of official contributions and electronic information. After completion, check the results of the system and preserve the correspondence between facilities, products and activities.

FDA's initial statement includes a general point of time to be submitted within thirty days of the commencement of the relevant activity or commercial distribution, specifying that offshore facilities must be registered prior to export to the United States and importers within the United States must be registered prior to import. Devices requiring pre-market clarance or approval shall meet the corresponding pre-conditions and cannot be postponed at normal points.

How can annual renewals and daily changes be maintained?

Annual registration is submitted from 1 October to 31 December of each year, even if the information remains unchanged; Review listings in the same window and submit applicable updates. Annual maintenance is not merely a payment; it should also confirm the actual submission and recording status.

Changes in address, activity, agent, manufacturing relationship, product listing or suspension restoration should be processed in a timely manner, in accordance with applicable requirements, and not always until the end of the year. See specific scope.Annual renewal and device listing updatesandChanges in registered listing information。

VI. How do official costs and service cycles distinguish?

FY 2027 (2026-10-01 to 2027-09-30) annual fee for establishment registration is US$ 13,785, and actual contribution obligations are checked by activity; There is no separate product-based fee charged for listing applications by Device Listing. Pre-market application fees, service charges and U.S. agent fees are recognized separately.

The extension fee exemption for a particular small business relates to SBD, financial difficulties and independent application conditions, which are not general discounts and do not apply to first registration. Preparation of information, confirmation of payments, authorization of account numbers and information verification all affect the completion of the plan; Obtaining records is not part of the FDA product approval cycle.

VII. Qualified problems and processing entrances

510(k) Can immunity not be registered?This cannot be understood directly. Pre-market notification of exemptions should be judged separately from registered listing obligations.

With a registration number, do you mean pass the FDA check?No. Registration and listing cannot be used as certificates of approval, certification or inspection by the FDA.

Do brands and factories need only one side?In accordance with the activities of the parties, it cannot be assumed that all other subjects are covered by the records of one party.

See you for the first time at the facilityFirst-time establishment registration service; See product matters.Denise Listing Service。 (a) A single entry under self-help is used for the relevant business register; The inclusion of listings, volume of products and follow-up maintenance shall be subject to the details of the goods and confirmation of the order, subject to the application of official fees.

VIII. REQUIREMENTS OFFICIAL RESOURCES AND INFORMATION

View medical device for first registration and preparation of information

Submission of product and business summaries, terms of reference and quotations

Official data checks and updates: 2026-11-06. Author: Mr. Otsun; Audit: Mr. Toto. Specific applicability and handling arrangements should be checked against the current FDA rules for the combination of equipment, entrepreneurial activities and FDA.

Continue reading and preparation

Further consolidation of project information is availableInitial medical device establishment registration; The scope, processing cycles and costs are shown on the corresponding service page.